A clinical trial to test the efficacy and safety of the transplantation of nasal cells to treat chronic spinal cord...
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis.
Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation from the International Leducq Foundation to further the development of a Strep A vaccine.
The National Health and Medical Research Council (NHMRC) has awarded $3.7 million over five years to intergenerational researchers across University...
The Institute for Glycomics’ malaria vaccine researchers are one step closer to human trials for a malaria vaccine that can be freeze-dried.
Griffith University’sClinical Trials Unit is the first globally to recruit patients for a multi-national rheumatology trial, and will also screen the first patient in Australia for a Meningococcal vaccine trial.
A $2million grant from Cancer Council of Queensland will help Griffith researchers continue vital work in bolstering survival rates in women treated for ovarian cancer.
Community mindedGriffith University nutrition and dietetics students have made a real difference to the lives of seniors and others who needed assistance during COVID-19.
The Governor-General, His Excellency General the Honourable Sir Peter Cosgrove AK MC (Retd), got first-hand insights into the world’s first...
